Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
316.89
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutic
< Previous
1
2
3
4
5
6
7
8
Next >
6 Analysts Have This to Say About United Therapeutics
December 05, 2022
Via
Benzinga
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
November 03, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
Via
Benzinga
United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease
September 20, 2022
Via
Benzinga
United Therapeutics: Return On Capital Employed Overview
August 08, 2022
Via
Benzinga
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
November 03, 2022
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
November 02, 2022
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
Via
Benzinga
Recap: United Therapeutics Q3 Earnings
November 02, 2022
United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
November 02, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference
November 01, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Posts Data From Remodulin Induction Before Orenitram Therapy In High Blood Pressure Patients
October 31, 2022
Via
Benzinga
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy
October 31, 2022
From
United Therapeutics Corporation
Via
Business Wire
Earnings Scheduled For November 2, 2022
November 02, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
Via
Benzinga
United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022
October 26, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting
October 14, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
October 11, 2022
From
United Therapeutics Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Upgrades
Via
Benzinga
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.
Via
InvestorPlace
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report
September 12, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation
August 31, 2022
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022
August 24, 2022
From
United Therapeutics Corporation
Via
Business Wire
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
Via
Investor Brand Network
Exposures
Product Safety
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill...
Via
FinancialNewsMedia
Exposures
Product Safety
United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
August 03, 2022
From
United Therapeutics Corporation
Via
Business Wire
Earnings Outlook For United Therapeutics
August 02, 2022
United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that United...
Via
Benzinga
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
August 05, 2022
The Nasdaq and small caps rose while the S&P 500 is hitting resistance.
Via
Investor's Business Daily
United Therapeutics Corporation to Report Second Quarter 2022 Financial Results Before the Market Opens on Wednesday, August 3, 2022
July 27, 2022
From
United Therapeutics Corporation
Via
Business Wire
7 Best Pharmaceutical Stocks to Buy Now
July 20, 2022
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.
Via
InvestorPlace
Swing Trading Stock Watchlist For The Week Of July 11 And Beyond
July 09, 2022
The stock market's health is improving, but a likely bottom has not been confirmed yet. That means I’m buying some stocks (swing trades), but I'm not loading up yet. Let's see what I'm looking at.
Via
Talk Markets
7 Biotech Stocks With Key Catalysts Coming in July
June 27, 2022
Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.